HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction
Metrics: PDF 786 views | HTML 2879 views | ?
Xing Chen1,*, Chenggang Clarence Yan2,*, Xu Zhang3, Zhu-Hong You4, Yu-An Huang5, Gui-Ying Yan6
1School of Information and Electrical Engineering, China University of Mining and Technology, Xuzhou, China
2Institute of Information and Control, Hangzhou Dianzi University, Hangzhou, China
3School of Mechanical, Electrical & Information Engineering, Shandong University, Weihai, China
4School of Computer Science and Technology, China University of Mining and Technology, Xuzhou, China
5Department of Computing, Hong Kong Polytechnic University, Hong Kong, China
6Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China
*The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
Xing Chen, email: email@example.com
Gui-Ying Yan, email: firstname.lastname@example.org
Keywords: microRNA, disease, microRNA-disease association, heterogeneous network, similarity
Received: May 12, 2016 Accepted: July 28, 2016 Published: August 12, 2016
Recently, microRNAs (miRNAs) have drawn more and more attentions because accumulating experimental studies have indicated miRNA could play critical roles in multiple biological processes as well as the development and progression of human complex diseases. Using the huge number of known heterogeneous biological datasets to predict potential associations between miRNAs and diseases is an important topic in the field of biology, medicine, and bioinformatics. In this study, considering the limitations in the previous computational methods, we developed the computational model of Heterogeneous Graph Inference for MiRNA-Disease Association prediction (HGIMDA) to uncover potential miRNA-disease associations by integrating miRNA functional similarity, disease semantic similarity, Gaussian interaction profile kernel similarity, and experimentally verified miRNA-disease associations into a heterogeneous graph. HGIMDA obtained AUCs of 0.8781 and 0.8077 based on global and local leave-one-out cross validation, respectively. Furthermore, HGIMDA was applied to three important human cancers for performance evaluation. As a result, 90% (Colon Neoplasms), 88% (Esophageal Neoplasms) and 88% (Kidney Neoplasms) of top 50 predicted miRNAs are confirmed by recent experiment reports. Furthermore, HGIMDA could be effectively applied to new diseases and new miRNAs without any known associations, which overcome the important limitations of many previous computational models.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.